Residual position errors of lymph node surrogates in breast cancer adjuvant radiotherapy: Comparison of two arm fixation devices and the effect of arm position correction.
Residual position errors of the lymph node (LN) surrogates and humeral head (HH) were determined for 2 different arm fixation devices in radiotherapy (RT) of breast cancer: a standard wrist-hold (WH) and a house-made rod-hold (RH). The effect of arm position correction (APC) based on setup images was also investigated. A total of 113 consecutive patients with early-stage breast cancer with LN irradiation were retrospectively analyzed (53 and 60 using the WH and RH, respectively). Residual position errors of the LN surrogates (Th1-2 and clavicle) and the HH were investigated to compare the 2 fixation devices. The position errors and setup margins were determined before and after the APC to investigate the efficacy of the APC in the treatment situation. A threshold of 5mm was used for the residual errors of the clavicle and Th1-2 to perform the APC, and a threshold of 7mm was used for the HH. The setup margins were calculated with the van Herk formula. Irradiated volumes of the HH were determined from RT treatment plans. With the WH and the RH, setup margins up to 8.1 and 6.7mm should be used for the LN surrogates, and margins up to 4.6 and 3.6mm should be used to spare the HH, respectively, without the APC. After the APC, the margins of the LN surrogates were equal to or less than 7.5/6.0mm with the WH/RH, but margins up to 4.2/2.9mm were required for the HH. The APC was needed at least once with both the devices for approximately 60% of the patients. With the RH, irradiated volume of the HH was approximately 2 times more than with the WH, without any dose constraints. Use of the RH together with the APC resulted in minimal residual position errors and setup margins for all the investigated bony landmarks. Based on the obtained results, we prefer the house-made RH. However, more attention should be given to minimize the irradiation of the HH with the RH than with the WH.
Department of Oncology, Tampere University Hospital (TAUH), Tampere, Finland; Department of Medical Physics, Tampere University Hospital (TAUH), Tampere, Finland.
Mika
M
Kapanen
Department of Oncology, Tampere University Hospital (TAUH), Tampere, Finland. Electronic address: Marko.Laaksomaa@pshp.fi.
Marko
M
Laaksomaa
Department of Oncology, Tampere University Hospital (TAUH), Tampere, Finland.
Tanja
T
Skyttä
Department of Oncology, Tampere University Hospital (TAUH), Tampere, Finland.
Mikko
M
Haltamo
Department of Oncology, Tampere University Hospital (TAUH), Tampere, Finland.
Jani
J
Pehkonen
Department of Oncology, Tampere University Hospital (TAUH), Tampere, Finland.
Turkka
T
Lehtonen
Department of Oncology, Tampere University Hospital (TAUH), Tampere, Finland; Medical School, University of Tampere, Tampere, Finland.
Pirkko-Liisa
PL
Kellokumpu-Lehtinen
Department of Medical Physics, Tampere University Hospital (TAUH), Tampere, Finland.
Simo
S
Hyödynmaa
D001943:Breast Neoplasms / Q000532:radiotherapy*; D005260:Female; D006801:Humans; D008198:Lymph Nodes; D008875:Middle Aged; D056888:Patient Positioning / Q000295:instrumentation*; D018714:Radiotherapy, Adjuvant
Adjuvant radiotherapy; Breast cancer; Fixation devices; Lymph nodes; Patient setup